Preparation and in vivo evaluation of spray dried matrix type controlled-release microparticles of tamsulosin hydrochloride for orally disintegrating tablet

References

• Johnson I, Theodore M, Jones K, Williford WO, Kutner MH, Issa MM, et al. Changes in nocturia from medical treatment of benign prostatic hyperplasia: Secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. J Urol, 2003;170:145–148.
   PubMed Web of Science ®Google Scholar
• O’Leary MP. (2001). Tamsulosin: Current clinical experience. Urology, 58:42–8; discussion 48.
   Web of Science ®Google Scholar
• Carruthers S. Adverse effects of α 1-adrenergic blocking drugs. Drug saf: An international journal of medical toxicology and drug experience, 1994;11:12–20.
   PubMed Web of Science ®Google Scholar
• Chapple C, Andersson KE. (2002). Tamsulosin: An overview. World J Urol, 19:397–404.
   PubMed Web of Science ®Google Scholar
• Wilde MI, McTavish D. (1996). Tamsulosin. A review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasia. Drugs, 52:883–898.
   PubMed Web of Science ®Google Scholar
• Matsushima H, Kamimura H, Soeishi Y, Watanabe T, Higuchi S, Tsunoo M. (1998). Pharmacokinetics and plasma protein binding of tamsulosin hydrochloride in rats, dogs, and humans. Drug Metab Dispos, 26:240–245.
   PubMed Web of Science ®Google Scholar
• Djavan B, Milani S, Davies J, Bolodeoku J. The impact of tamsulosin oral controlled absorption system (OCAS) on nocturia and the quality of sleep: Preliminary results of a pilot study. Eur Urol Suppl, 2005;4:61–68.
   Web of Science ®Google Scholar
• Kim MS, Jun SW, Lee S, Lee TW, Park JS, Hwang SJ. (2005). The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form. J Pharm Pharmacol, 57:735–742.
   PubMed Web of Science ®Google Scholar
• Kim MS, Park GD, Jun SW, Lee S, Park JS, Hwang SJ. (2005). Controlled release tamsulosin hydrochloride from alginate beads with waxy materials. J Pharm Pharmacol, 57:1521–1528.
   PubMed Web of Science ®Google Scholar
• Kim JS, Kim MS, Park HJ, Lee S, Park JS, Hwang SJ. (2007). Statistical optimization of tamsulosin hydrochloride controlled release pellets coated with the blend of HPMCP and HPMC. Chem Pharm Bull, 55:936–939.
   PubMed Web of Science ®Google Scholar
• Kim MS, Kim JS, You YH, Park HJ, Lee S, Park JS et al. (2007). Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology. Int J Pharm, 341:97–104.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tang X, Yang R. (2009). Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets. Drug Dev Ind Pharm, 35:26–33.
   PubMed Web of Science ®Google Scholar
• Park JS, Shim JY, Park JS, Lee MJ, Kang JM, Lee SH et al. (2011). Formulation variation and in vitro-in vivo correlation for a rapidly swellable three-layered tablet of tamsulosin HCl. Chem Pharm Bull, 59:529–535.
   PubMed Web of Science ®Google Scholar
• Michel MC, Mehlburger L, Bressel HU, Schumacher H, Schäfers RF, Goepel M. (1998). Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: Does co-morbidity alter tolerability? J Urol, 160:784–791.
   PubMed Web of Science ®Google Scholar
• Fu Y, Yang S, Jeong SH, Kimura S, Park K. (2004). Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst, 21:433–476.
   PubMed Web of Science ®Google Scholar
• Chang RK, XIAODI G, Burnside BA, Couch RA. Fast-dissolving tablets. Pharmaceut Tech, 2000;24:52–58.
   Google Scholar
• Maeda A, Shinoda T, Ito N, Baba K, Oku N, Mizumoto T. (2011). Evaluating tamsulosin hydrochloride-released microparticles prepared using single-step matrix coating. Int J Pharm, 408:84–90.
   PubMed Web of Science ®Google Scholar
• Mizumoto T. Development of modified-release fast disintegrating tablet (Harnal®-D) containing fine, modified-release particles. Membrane, 2008;33:82–84.
   Google Scholar
• Baker RW. Controlled release of biologically active agents. John Wiley & Sons; 1987.
   Google Scholar
• Huang X, Brazel CS. (2001). On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release, 73:121–136.
   PubMed Web of Science ®Google Scholar
• SOT SoT. Guiding Principles in the Use of Animals in Toxicology. 2008; Available from: www.toxicology.org/AI/FA/guidingprinciples.pdf.
   Google Scholar
• Ramakrishna NV, Vishwottam KN, Manoj S, Koteshwara M, Wishu S, Varma DP. (2005). Rapid, simple and highly sensitive LC-ESI-MS/MS method for the quantification of tamsulosin in human plasma. Biomed Chromatogr, 19:709–719.
   PubMed Web of Science ®Google Scholar
• Baras B, Benoit MA, Gillard J. (2000). Parameters influencing the antigen release from spray-dried poly(DL-lactide) microparticles. Int J Pharm, 200:133–145.
   PubMed Web of Science ®Google Scholar
• Kovár M, Mrkvan T, Strohalm J, Etrych T, Ulbrich K, Stastný M et al. (2003). HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia. J Control Release, 92:315–330.
   PubMed Web of Science ®Google Scholar
• Alves GP, Santana MHA. Phospholipid dry powders produced by spray drying processing: Structural, thermodynamic and physical properties. Powder Tech, 2004;145:139–148.
   Web of Science ®Google Scholar
• Zijlstra GS, Hinrichs WL, de Boer AH, Frijlink HW. (2004). The role of particle engineering in relation to formulation and de-agglomeration principle in the development of a dry powder formulation for inhalation of cetrorelix. Eur J Pharm Sci, 23:139–149.
   PubMed Web of Science ®Google Scholar
• Maury M, Murphy K, Kumar S, Mauerer A, Lee G. (2005). Spray-drying of proteins: Effects of sorbitol and trehalose on aggregation and FT-IR amide I spectrum of an immunoglobulin G. Eur J Pharm Biopharm, 59:251–261.
   PubMed Web of Science ®Google Scholar
• Ameri M, Maa., YF. Spray drying of biopharmaceuticals: Stability and process considerations. Dry Technol, 2006;24:763–768.
   Web of Science ®Google Scholar
• Vehring R. (2008). Pharmaceutical particle engineering via spray drying. Pharm Res, 25:999–1022.
   PubMed Web of Science ®Google Scholar
• Lecomte F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. (2005). pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: Elucidation of the underlying mass transport mechanisms. Pharm Res, 22:1129–1141.
   PubMed Web of Science ®Google Scholar
• Siepmann F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. (2005). Blends of aqueous polymer dispersions used for pellet coating: Importance of the particle size. J Control Release, 105:226–239.
   PubMed Web of Science ®Google Scholar
• Rujivipat S, Bodmeier R. (2010). Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends. Eur J Pharm Biopharm, 76:486–492.
   PubMed Web of Science ®Google Scholar
• Segot-Chicq S, Peppas NA. Solute and penetrant diffusion in swellable polymers IV. Semicrystalline, swelling-controlled release systems of poly(ethylene-co-vinyl alcohol). J Contr Release, 1986;3:193–204.
   Google Scholar
• Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
   PubMed Web of Science ®Google Scholar
• Arifin DY, Lee LY, Wang CH. (2006). Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. Adv Drug Deliv Rev, 58:1274–1325.
   PubMed Web of Science ®Google Scholar
• Brazel CS, Peppas NA. Mechanisms of solute and drug transport in relaxing, swellable, hydrophilic glassy polymers. Polymer, 1999;40:3383–3398.
   Web of Science ®Google Scholar
• Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139–157.
   PubMed Web of Science ®Google Scholar
• Colombo P, Bettini R, Massimo G, Catellani PL, Santi P, Peppas NA. (1995). Drug diffusion front movement is important in drug release control from swellable matrix tablets. J Pharm Sci, 84:991–997.
   PubMed Web of Science ®Google Scholar
• Gohel MC, Nagori SA. (2009). Fabrication of modified transport fluconazole transdermal spray containing ethyl cellulose and Eudragit RS100 as film formers. AAPS PharmSciTech, 10:684–691.
   PubMed Web of Science ®Google Scholar
• Rodríguez M, Vila-Jato JL, Torres D. (1998). Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release, 55:67–77.
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Yamamoto H, Takeuchi H, Kawashima Y. (2003). Microsphere design for the colonic delivery of 5-fluorouracil. J Control Release, 90:313–322.
   PubMed Web of Science ®Google Scholar